European Case Law Identifier: | ECLI:EP:BA:2005:T037802.20051012 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 12 October 2005 | ||||||||
Case number: | T 0378/02 | ||||||||
Application number: | 89905449.8 | ||||||||
IPC class: | C12Q 1/68 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Method and apparatus for analysing polynucleotide sequences | ||||||||
Applicant name: | OXFORD GENE TECHNOLOGY LIMITED | ||||||||
Opponent name: | 01: Hyseq Inc. 02: Nanogen Inc. 03: F.HOFFMANN-LA ROCHE & CO. 04: Abbott Laboratories 05: Multilyte Ltd. 06: Vysis Corp. |
||||||||
Board: | 3.3.04 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: | |||||||||
Keywords: | Novelty, inventive step, sufficiency of disclosure, clarity (yes), added subject-matter, extension of scope of protection (no) | ||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t020378eu1.html
Date retrieved: 17 May 2021